振江股份(603507.SH):上半年淨利潤同比預減81.78%到87.85%
格隆匯7月14日丨振江股份(603507.SH)公佈2025年半年度業績預告,預計2025年半年度實現歸屬於上市公司股東的淨利潤爲1,500萬元到2,250萬元,同比減少81.78%到87.85%。公司預計歸屬於上市公司股東的扣除非經常性損益的淨利潤爲7,000萬元到9,000萬元,同比減少25.33%到41.92%。
報告期內,公司業績出現同比下滑,主要歸因於兩方面因素:一方面,外匯鎖匯等非經常性損失同比顯著增加,對當期利潤形成直接拖累;另一方面,南通一期項目等新投擴產項目尚處於產能爬坡階段,產能未能實現充分有效釋放,導致相關固定攤銷費用居高不下,進一步擠壓了利潤空間。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.